Taro Pharmaceutical Industries Ltd (TARO.N)
|Market Cap (Mil.):||$6,902.32|
|Shares Outstanding (Mil.):||42.83|
Reuters Market Eye - Shares of Sun Pharmaceutical Industries Ltd fall 0.9 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates.
* Shares of India's Sun Pharmaceutical Industries Ltd fall 0.8 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates. * Taro's revenue in January-March grew by 13 percent to $187 million, while profit jumped by 82 percent to $90 million. * Sun Pharma is scheduled to report its Jan-March results on Thursday. (firstname.lastname@example.org / email@example.com)
MUMBAI - Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
|Ranbaxy Laboratories Limited (RANB.NS)||Rs657.60||+21.15|
|Pfizer Inc. (PFE.N)||$29.20||-0.19|
|Novartis AG (NOVN.VX)||CHF85.80||-0.10|
|Merck & Co., Inc. (MRK.N)||$59.75||-0.36|
|Bayer AG (BAYGn.DE)||€102.60||-0.05|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,454.50p||-5.50|
|Eli Lilly and Co (LLY.N)||$63.56||0.00|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||18,850.00₪||+140.00|
|Bristol-Myers Squibb Co (BMY.N)||$50.37||-0.28|